Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 13/20 | 0.46 |
| ▸ | TACR1 | P25103 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6597044 | 0.96 | TACR2 (0.43) | TACR2TACR1 | |
| SCHEMBL6599007 | 0.95 | TACR2 (0.48) | TACR2TACR1 | |
| SCHEMBL6598988 | 0.95 | TACR2 (0.45) | TACR2TACR1 | |
| SCHEMBL6593545 | 0.94 | LMNA (0.44) | TACR2LMNA | |
| SCHEMBL6594803 | 0.94 | TACR2 (0.49) | TACR2TACR1 | |
| SCHEMBL6593738 | 0.94 | TACR2 (0.42) | TACR2TACR1 | |
| SCHEMBL6600543 | 0.93 | TACR2 (0.48) | TACR2TACR1 | |
| SCHEMBL6598874 | 0.92 | TACR2 (0.44) | TACR2TACR1LMNA | |
| SCHEMBL6598106 | 0.92 | TACR2 (0.59) | TACR2TACR1 | |
| SCHEMBL6596425 | 0.92 | TACR2 (0.47) | TACR2TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888338-B1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | AVENTIS PHARMA INC (US) | 2004-11-17 | — | — | EP | disclosed |